JP2007277274A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007277274A5 JP2007277274A5 JP2007200862A JP2007200862A JP2007277274A5 JP 2007277274 A5 JP2007277274 A5 JP 2007277274A5 JP 2007200862 A JP2007200862 A JP 2007200862A JP 2007200862 A JP2007200862 A JP 2007200862A JP 2007277274 A5 JP2007277274 A5 JP 2007277274A5
- Authority
- JP
- Japan
- Prior art keywords
- manganese
- wrinkles
- gluconate
- organic
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000037303 wrinkles Effects 0.000 claims 6
- 239000002537 cosmetic Substances 0.000 claims 5
- 150000002696 manganese Chemical class 0.000 claims 4
- 235000014012 manganese gluconate Nutrition 0.000 claims 4
- 239000011683 manganese gluconate Substances 0.000 claims 4
- 229940072543 manganese gluconate Drugs 0.000 claims 4
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 claims 4
- OAVRWNUUOUXDFH-UHFFFAOYSA-H 2-hydroxypropane-1,2,3-tricarboxylate;manganese(2+) Chemical compound [Mn+2].[Mn+2].[Mn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O OAVRWNUUOUXDFH-UHFFFAOYSA-H 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 229940071125 manganese acetate Drugs 0.000 claims 2
- 235000006748 manganese carbonate Nutrition 0.000 claims 2
- 239000011656 manganese carbonate Substances 0.000 claims 2
- 229940093474 manganese carbonate Drugs 0.000 claims 2
- 235000014872 manganese citrate Nutrition 0.000 claims 2
- 239000011564 manganese citrate Substances 0.000 claims 2
- 229940097206 manganese citrate Drugs 0.000 claims 2
- XYXLRVFDLJOZJC-CVBJKYQLSA-L manganese(2+);(z)-octadec-9-enoate Chemical compound [Mn+2].CCCCCCCC\C=C/CCCCCCCC([O-])=O.CCCCCCCC\C=C/CCCCCCCC([O-])=O XYXLRVFDLJOZJC-CVBJKYQLSA-L 0.000 claims 2
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 claims 2
- RGVLTEMOWXGQOS-UHFFFAOYSA-L manganese(2+);oxalate Chemical compound [Mn+2].[O-]C(=O)C([O-])=O RGVLTEMOWXGQOS-UHFFFAOYSA-L 0.000 claims 2
- 229910000016 manganese(II) carbonate Inorganic materials 0.000 claims 2
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 206010033675 panniculitis Diseases 0.000 claims 1
- 210000004304 subcutaneous tissue Anatomy 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0006373A FR2809005B1 (fr) | 2000-05-18 | 2000-05-18 | Utilisation du manganese dans le traitement des rides |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001150108A Division JP2002003387A (ja) | 2000-05-18 | 2001-05-18 | シワの処理におけるマンガンの用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007277274A JP2007277274A (ja) | 2007-10-25 |
| JP2007277274A5 true JP2007277274A5 (enExample) | 2008-07-03 |
Family
ID=8850377
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001150108A Ceased JP2002003387A (ja) | 2000-05-18 | 2001-05-18 | シワの処理におけるマンガンの用途 |
| JP2007200862A Withdrawn JP2007277274A (ja) | 2000-05-18 | 2007-08-01 | シワの処理におけるマンガンの用途 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001150108A Ceased JP2002003387A (ja) | 2000-05-18 | 2001-05-18 | シワの処理におけるマンガンの用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20020028254A1 (enExample) |
| EP (1) | EP1155686A1 (enExample) |
| JP (2) | JP2002003387A (enExample) |
| BR (1) | BR0101995A (enExample) |
| CA (1) | CA2348102A1 (enExample) |
| FR (1) | FR2809005B1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2850573B1 (fr) * | 2003-02-03 | 2006-07-07 | Oreal | Utilisation de l'acide 3-0-acetyl 11-ceto-boswellique ou d'un extrait vegetal en contenant, pour reduire les rides d'expression |
| FR2863164B1 (fr) * | 2003-12-04 | 2006-02-24 | Silab Sa | Procede d'obtention d'un principe actif a partir de pimpinella anisum, principe actif obtenu et application cosmetique |
| CA2562871C (en) | 2004-02-20 | 2014-06-10 | Human Matrix Sciences, Llc | Iron based compounds for elastogenesis and connective tissue treatment |
| FR2868309B1 (fr) * | 2004-04-02 | 2006-05-26 | Oreal | Utilisation cosmetique d'au moins un inhibiteur d'hmg-coa-reductase comme agent destine a prevenir et/ou lutter contre les rides d'expression |
| JP2008510852A (ja) * | 2004-08-17 | 2008-04-10 | インヴィトロジェン コーポレーション | 高発光性コロイド粒子の合成 |
| JP2008536797A (ja) | 2004-12-29 | 2008-09-11 | ラボ コスプロファー アクチェンゲゼルシャフト | 表情皺を緩和するのに好適な皮膚投与のための美容組成物 |
| US7566693B2 (en) | 2005-02-22 | 2009-07-28 | Human Matrix Sciences, Llc | Elastin protective polyphenolics and methods of using the same |
| US8114829B2 (en) | 2005-02-22 | 2012-02-14 | Human Matrix Sciences, Llc | Elastin protective polyphenolics and methods of using the same |
| US8642578B2 (en) | 2005-03-29 | 2014-02-04 | Human Matrix Sciences, Llc | Elastin protective polyphenolics and methods of using the same |
| ES2259928B1 (es) | 2005-04-08 | 2007-11-01 | Lipotec, S.A. | Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales. |
| FR2893501B1 (fr) * | 2005-11-21 | 2014-03-14 | Oreal | Compositions topiques pour favoriser l'homeostasie de la peau |
| FR2909552B1 (fr) | 2006-12-12 | 2009-11-20 | Oreal | Utilisation cosmetique de l'acide anisique pour favoriser la desquamation |
| US8728439B2 (en) * | 2008-03-31 | 2014-05-20 | Celtrast Llc | System and method for indirectly measuring calcium ion efflux |
| FR2932086A1 (fr) * | 2008-06-06 | 2009-12-11 | Lvmh Rech | Methode de soin cosmetique anti-age par stimulation de l'expression de la survivine |
| WO2010093635A2 (en) | 2009-02-10 | 2010-08-19 | Celtrast Llc | Systems and methods for measuring and modeling in vivo manganese ion transport in a subject |
| FR2953716B1 (fr) | 2009-12-16 | 2015-03-27 | Oreal | Kit de formulation d'un produit cosmetique |
| US20110305735A1 (en) | 2010-06-09 | 2011-12-15 | Lipotec, S.A. | Skin antiaging treatment |
| CN106456469A (zh) * | 2014-04-28 | 2017-02-22 | 堺化学工业株式会社 | 化妆料 |
| FR3061002B1 (fr) | 2016-12-23 | 2019-05-24 | L'oreal | Composition comprenant de l’acide hydroxyethylpiperazine ethane sulfonique et au moins un alkylpolyglucoside |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2612775B1 (fr) * | 1987-03-25 | 1991-10-11 | Thorel Jean | Compositions pour la prevention et le traitement de la degenerescence cutanee |
| EP0424033A3 (en) * | 1989-10-19 | 1991-07-31 | Pola Chemical Industries Inc | External skin preparation |
| FR2675997B1 (fr) * | 1991-05-03 | 1993-12-24 | Oreal | Composition topique anti radicaux libres a base de superoxyde-dismutase et d'un derive phosphonique. |
| US5496827A (en) * | 1994-07-15 | 1996-03-05 | Patrick; Jay | Compositions for the transdermal delivery of nutrients |
| EP0799018A4 (en) * | 1994-12-21 | 2000-03-29 | Cosmederm Technologies | FORMULATIONS AND METHODS FOR REDUCING SKIN IRRITATION |
| FR2740335B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p |
| GB2307175A (en) * | 1995-11-14 | 1997-05-21 | Steifel Lab Inc | Topical composition comprising a transition metal and bicarbonate ions, particularly for the promotion of pigmentation |
| JP3608059B2 (ja) * | 1995-12-05 | 2005-01-05 | 株式会社アドバンス | 化粧料 |
| US5925348A (en) * | 1996-02-23 | 1999-07-20 | Medical Doctor's Research Institute, Inc. | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin |
| FR2746641B1 (fr) * | 1996-03-27 | 1998-06-05 | Oreal | Utilisation d'un extrait d'au moins une iridacee dans le traitement des rides |
| US6471972B1 (en) * | 1996-11-07 | 2002-10-29 | Lvmh Recherche | Cosmetic treatment method for fighting against skin ageing effects |
| FR2779059B1 (fr) * | 1998-05-29 | 2004-09-10 | Guerlain | Procede de traitement cosmetique pour lutter contre les effets du vieillissement cutane; nouvelles compositions cosmetiques pour sa mise en oeuvre |
| US5804594A (en) * | 1997-01-22 | 1998-09-08 | Murad; Howard | Pharmaceutical compositions and methods for improving wrinkles and other skin conditions |
| US6149924A (en) * | 1998-07-20 | 2000-11-21 | Biomed Research & Technologies, Inc. | Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin |
| FR2791260B1 (fr) * | 1999-03-26 | 2003-06-06 | Dior Christian Parfums | Compositions cosmetiques ou dermatologiques contenant au moins une substance destinee a augmenter la fonctionnalite et/ou l'expression des recepteurs membranaires cd44 des cellules de la peau |
-
2000
- 2000-05-18 FR FR0006373A patent/FR2809005B1/fr not_active Expired - Lifetime
-
2001
- 2001-04-27 EP EP01401110A patent/EP1155686A1/fr not_active Withdrawn
- 2001-05-04 BR BR0101995-3A patent/BR0101995A/pt not_active IP Right Cessation
- 2001-05-16 CA CA002348102A patent/CA2348102A1/fr not_active Abandoned
- 2001-05-18 JP JP2001150108A patent/JP2002003387A/ja not_active Ceased
- 2001-05-18 US US09/859,384 patent/US20020028254A1/en not_active Abandoned
-
2003
- 2003-11-07 US US10/702,736 patent/US20040096520A1/en not_active Abandoned
-
2007
- 2007-08-01 JP JP2007200862A patent/JP2007277274A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007277274A5 (enExample) | ||
| BRPI0923589A2 (pt) | uso de uma composição espumável essencialmente livre de ingredientes farmaceuticamente ativos para o tratamento da pele humana. | |
| JP2006131645A5 (enExample) | ||
| JP2006523212A5 (enExample) | ||
| JP2007538008A5 (enExample) | ||
| BRPI0700678A (pt) | método para aperfeiçoar comportamentos de sono | |
| JP2006502236A5 (enExample) | ||
| NZ586302A (en) | Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising | |
| JP2010530001A5 (enExample) | ||
| JP2004526758A5 (enExample) | ||
| HRP20211983T1 (hr) | Pripravci za i postupci stimuliranja matičnih stanica | |
| JP2017514825A5 (enExample) | ||
| BRPI0811273A2 (pt) | Composição anti-envelhecimento para cuidado da pele, e, método de tratamento cosmético da pele | |
| WO2015038552A3 (en) | Aspirin formulation for increased efficacy | |
| WO2012051614A3 (en) | Delivery of hydrophobic bioactive agents | |
| JP2010001264A5 (enExample) | ||
| MX338975B (es) | Composicion farmaceutica que contiene sales de citrato y bicarbonato, y su uso para el tratamiento de la cistinuria. | |
| PL2165704T3 (pl) | Zastosowanie alweryny w leczeniu dolegliwości skórnych | |
| JP2016501208A5 (enExample) | ||
| DK2004235T3 (da) | Sammensætning til kosmetisk eller farmaceutisk-dermatologisk anvendelse | |
| WO2008034989A3 (fr) | Utilisation d'un extrait de quinoa comme actif cosmetique et pharmaceutique amincissant et/ou comme actif prevenant de la formation de nouvelles graisses dans le corps humain | |
| BRPI0810682A2 (pt) | agente antitumoral em especial para o tratamento de tumores dérmicos, fármaco, kit compreendendo fármaco. | |
| WO2009066938A3 (en) | Composition for preventing gray hair and for treatment of leukoplakia containing arrowroot | |
| WO2010028515A3 (es) | Una composición farmacéutica dermatológica, a base de pentoxifilina, de aplicación tópica, en forma de crema, gel ungüento, solución, en emulsión, en liposomas y en microcápsulas | |
| WO2007138233A3 (fr) | Utilisation du zatosetron pour le traitement de la rosacee |